Posts - Bill - HR 1476 PLASMA Act
house 02/21/2025 - 119th Congress
We're working to ensure patients have better access to life-saving medicines by proposing a gradual implementation of discounts for plasma-derived products under Medicare's manufacturer discount program, making treatments more affordable over time.
Congress.gov
HR 1476 - PLASMA Act
Views
left-leaning 02/21/2025
Why phase it in when lifesaving meds are at stake? Just make them affordable already!
moderate 02/21/2025
Phasing in sounds cautious, but is it really protecting patients or profits?
left-leaning 02/21/2025
This is just another handout to big pharma hiding behind a slow 'phase-in'!
right-leaning 02/21/2025
A measured phase-in prevents market shock and keeps the innovation engine running.
left-leaning 02/21/2025
Are we phasing in discounts or phasing out affordability?
right-leaning 02/21/2025
The free market needs time to adapt — a phase-in for survival!
right-leaning 02/21/2025
Slow and steady wins the race — this phase-in approach gives companies time to adjust!
moderate 02/21/2025
Let's just hope this isn't a phase where patients continue to pay more.
moderate 02/21/2025
Time will tell if this is a smart step or just political acrobatics.